Mediforum Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2016-02-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.gmediforum.com
A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease
Phase 2
Recruiting
- Conditions
- Mild Alzheimer Disease
- Interventions
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Mediforum Ltd., Co.
- Target Recruit Count
- 312
- Registration Number
- NCT05811000
- Locations
- 🇰🇷
Mediforum, Seoul, Seongdon-gu, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath